Overcoming negative immune regulatory feedback loops in dendritic cells: basis for a next generation of cancer vaccines

被引:0
|
作者
Dohnal, A. [1 ]
Luger, R. [1 ]
Halfmann, A. [1 ]
Vittori, S. [1 ]
Vakookaran, S. [1 ]
Schuh, C. [1 ]
Erhart, F. [1 ]
Gaestel, M. [2 ]
Felzmann, T. [1 ,3 ]
机构
[1] St Anna Childrens Canc Res Inst, Vienna, Austria
[2] Hannover Med Sch, Inst Biochem, D-3000 Hannover, Germany
[3] Trimed Biotech GmbH, Vienna, Austria
来源
ONKOLOGIE | 2010年 / 33卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:287 / 287
页数:1
相关论文
共 47 条
  • [31] Next-generation proteasome inhibitor oprozomib enhances sensitivity to doxorubicin in triple-negative breast cancer cells
    Shi, Yonghua
    Bieerkehazhi, Shayahati
    Ma, Hong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2018, 11 (05): : 2347 - 2355
  • [32] Next-generation RNA sequencing identifies UHRF1 as a key regulatory protein in triple-negative breast cancer survival
    Solzak, Jeffrey P.
    Atale, Rutuja
    Radovich, Milan
    CANCER RESEARCH, 2013, 73 (08)
  • [33] Next-Generation CEA-CAR-NK-92 Cells against Solid Tumors: Overcoming Tumor Microenvironment Challenges in Colorectal Cancer
    Franzen, Alexander Sebastian
    Boulifa, Abdelhadi
    Radecke, Clarissa
    Stintzing, Sebastian
    Raftery, Martin J.
    Pecher, Gabriele
    CANCERS, 2024, 16 (02)
  • [34] Longitudinal analysis of circulating tumor cells and cell free tumor DNA by next generation sequencing in triple negative breast cancer
    Howard, K.
    Austin, S.
    Ramirez, A. B.
    Ritter, L.
    Boles, D.
    Pruitt, J.
    Collins, H.
    Mahen, E.
    Leonti, A.
    Maassel, L.
    Subia, C.
    Tuuli, S.
    Heying, N.
    Deutsch, K.
    Cox, J.
    Lo, F. Y.
    Stilwell, J. L.
    Kaldjian, E. P.
    Dorschner, M.
    Blau, S.
    Blau, A.
    Eisenberg, M.
    Anderson, S.
    Madan, A.
    CANCER RESEARCH, 2016, 76
  • [35] Natural killer and dendritic cells collaborate in the immune response induced by Cetuximab and IL-15 against triple negative breast cancer
    Julia, Estefania P.
    Betina Pampena, Maria
    Rocca, Yamila S.
    Mordoh, Jose
    Levy, Estrella M.
    CANCER IMMUNOLOGY RESEARCH, 2017, 5 (03)
  • [36] RELATIVE CONTRIBUTION OF CD 127 NEGATIVE SELECTION, RAPAMYCIN, AND TGF-β TO THE GENERATION OF HUMAN REGULATORY T CELLS THAT INHIBIT ALLOREACTIVITY VIA DENDRITIC CELL MODULATION
    Amarnath, S.
    Foley, J.
    Mariotti, J.
    Costanzo, C. M.
    Ryan, K.
    Fong, T.
    Warner, N.
    Fowler, D. H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 123 - 124
  • [37] CD74 promotes the formation of an immunosuppressive tumor microenvironment in triple-negative breast cancer in mice by inducing the expansion of tolerogenic dendritic cells and regulatory B cells
    Pellegrino, Bianca
    David, Keren
    Rabani, Stav
    Lampert, Bar
    Tran, Thuy
    Doherty, Edward
    Piecychna, Marta
    Meza-Romero, Roberto
    Leng, Lin
    Hershkovitz, Dov
    Vandenbark, Arthur A.
    Bucala, Richard
    Becker-Herman, Shirly
    Shachar, Idit
    PLOS BIOLOGY, 2024, 22 (11)
  • [38] Next Generation CD44v6-Specific CAR-NK Cells Effective against Triple Negative Breast Cancer
    Raftery, Martin J.
    Franzen, Alexander Sebastian
    Radecke, Clarissa
    Boulifa, Abdelhadi
    Schoenrich, Guenther
    Stintzing, Sebastian
    Blohmer, Jens-Uwe
    Pecher, Gabriele
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (10)
  • [39] A Negative Feedback Regulatory Loop Associates the Tyrosine Kinase Receptor ERBB2 and the Transcription Factor GATA4 in Breast Cancer Cells
    Hua, Guoqiang
    Zhu, Bing
    Rosa, Frederic
    Deblon, Nicolas
    Adelaide, Jose
    Kahn-Perles, Brigitte
    Birnbaum, Daniel
    Imbert, Jean
    MOLECULAR CANCER RESEARCH, 2009, 7 (03) : 402 - 414
  • [40] HER3 reactivation: A compensatory shift between Akt-mediated positive and negative feedback loops in HER2-overexpressed human breast cancer cells
    Tang, Patrick Ming Kuen
    Leung, Fenix
    Gijsen, Merel
    Harris, Adrian L.
    Kong, Anthony
    CANCER RESEARCH, 2011, 71